https://www.selleckchem.com/pr....oducts/-r-s--3-5-dhp
S.-only perspectives. Under "Screening" versus "No Screening", an estimated 179 active tuberculosis cases and 119 hospitalizations would be averted in the United States annually via predeparture treatment. From the U.S.-only perspective, this program would result in annual net cost savings of about $3.75 million. However, rom the multinational perspective, the screening program would cost $151,388 per U.S. case averted for Indian NIVs and $221,088 per U.S. case averted for Mexican NIVs. From the U.S.-only perspective, the screeni
Curtir
Comentario
Compartilhar
